However, the mechanisms of atheroprotection are largely unknown.
The prostaglandin PGI 2 exhibits properties of relevance to atheroprotection, inhibiting platelet activation, vascular smooth muscle contraction and proliferation (4), leukocyte-endothelial cell interactions (5) , and cholesteryl ester hydrolase (6) . PGI 2 analogs retard atherogenesis (7) , and atherosclerotic lesions exhibit a decreased capacity to produce PGI 2 ex vivo (8) . Cyclooxygenase 2 (COX-2), expressed in vascular endothelial cells (9) , catalyzes prostaglandin endoperoxide formation from arachidonic acid. This is subsequently transformed to PGI 2 by PGI 2 synthase (PGIS), a process that occurs in endothelial cells (10) . Selective COX-2 inhibitors depress PGI 2 metabolite excretion (11) . Inhibition of the COX-2-PGIS pathway may have particular relevance to atheroprotection in females because E 2 increases COX-2 expression in vascular tissues and augments PGI 2 production in vitro (12) .
Mice lacking the low density lipoprotein (LDL) receptor (LDLR KO) were examined to address the role of PGI 2 in gender-dependent atheroprotection; males develop atherosclerosis more rapidly than females (13) . No differences 1 The Institute for Translational Medicine and Therapeutics, University of Pennsylvania, PA 19104, USA. Percentage aortic lesion areas (stained red) in female and male LDLR KO and IP/LDLR DKO mice showed no significant difference between male IP/LDLR DKO and LDLR KO mice fed a high-fat diet for similar durations. IP deletion accelerated atherosclerosis at both time points in female mice only. IP/LDLR DKO females have a greater % lesion area (*P G 0.001 versus LDLR KO at 3 months, # P G 0.05 at 6 months). Data are given as the mean T SEM, n 0 10 to 13 mice per group. (E) Excretion of urinary 2,3-dinor TxB 2 (Tx-M) in LDLR KO and IP/ LDLR DKO mice at baseline and after being fed a high-fat diet for 3 and 6 months. Coincidental IP deletion increases Tx-M excretion in female mice (F 0 14.83, P G 0.001). Pairwise comparisons reveal significant differences at baseline (*P G 0.05) and at 3 months (**P G 0.01). (F) Male IP/LDLR DKO mice do not have elevated Tx-M biosynthesis at baseline, but upon being fed a high-fat diet, show a significant increase (all males: F 0 6.14, P G 0.01; all females: F 0 8.17, P G 0.01). This is accounted for by a difference after 3 months (**P G 0.01). Data are given as the mean T SEM, n 0 10 to 13 mice per group. in plasma total cholesterol or high density lipoprotein (HDL) cholesterol were observed among groups (table S1). Body weight increased as the animals aged, but there were no differences with genotype. En face aortae analyses showed that the extent of atherosclerosis was greater at 3 and 6 months in males than in females (Fig. 1, A and B) . Female mice lacking both the PGI 2 receptor (IP) and the LDLR (IP/LDLR DKO) developed greater aortic lesions than LDLR KO females after 3 months (5.6 T 1.1% versus 2.2 T 0.2%) and 6 months (23.2 T 1.4% versus 15.0 T 1.2%). This effect was gene dose dependent ( Fig. 1C) and was not observed in male mice (Fig. 1D ). There was a trend of greater lesion area in the IP/LDLR KO males than in LDLR KO males (5.95 T 1.1%, n 012, versus 3.83 T 0.5%, n 012) at 3 months, but this did not attain significance and was not evident at 6 months.
Platelet activation facilitates early atherogenesis and is reflected by the presence of the thromboxane metabolite 2,3-dinor TxB 2 (Tx-M) in urine. IP deletion increases urinary Tx-M in response to vascular injury (4) and increased urinary Tx-M in IP/LDLR DKO mice, compared to LDLR KO mice (Fig. 1, E and F) . This effect was evident in both genders at 3 months. Although urinary Tx-M was higher in male than in female LDLR KO mice (32.8 T 3.2 versus 20.5 T 3.0 ng/mg creatinine), additional deletion of the IP elevated Tx-M excretion in females to exceed those in male IP/LDLR DKO mice at baseline. Thus, PGI 2 decreases the platelet activation that accompanies early atherogenesis in female mice.
Oxidative stress increases lipid peroxidation, an effect reflected by the increased excretion of urinary isoprostanes (iPs) (14) . One of the most abundant iPs in urine, 8,12-iso-iPF 2a -VI, increased in LDLR KO mice during atherogenesis (Fig. 2 ). Although IP deletion had no effect in male IP/LDLR DKO mice (F 0 1.77, P 0 0.2) ( Fig. 2A) , its absence increased lipid peroxidation in female IP/LDLR DKO mice (F 0 15.8, P G 0.0005). This was particularly evident at baseline (8.7 T 2.6 versus 2.8 T 0.3 ng/mg creatinine, P G 0.05) and at 3 months (8.8 T 1.1 versus 2.8 T 0.4 ng/mg creatinine, P G 0.001) (Fig. 2B ), indicating that PGI 2 serves an antioxidant function in female LDLR KO mice prior to, and at initiation of, atherogenesis.
Given the importance of oxidant stress in atherogenesis (14), we examined the effect of PGI 2 in cultured mouse aortic smooth muscle cells (MASMCs) exposed to hydrogen peroxide (H 2 O 2 ) (15). This treatment increased PGI 2 synthesis (16) and lipid peroxidation, and the latter was augmented by IP deletion (Fig. 2C ). COX-2 expression was not affected (16) . H 2 O 2 treatment increased reactive oxygen species in MASMCs, as shown by the fluorescent probe dichlorofluorescein (17) . Absence of IP expression increased this effect (Fig. 2D ), suggesting that IP modulates oxidant stress under basal conditions. Cicaprost (100 nM), an IP agonist, limited the response of MASMCs to H 2 O 2 with subsequent reduction of lipid peroxidation (fig. S1A) but did not affect unstimulated cells. Cicaprost also increased expression of the antioxidant heme oxygenase 1 (HO1) in an IP-dependent manner (Fig. 2E) , whereas IP deletion decreased aortic HO1 expression in female IP/LDLR DKO mice (Fig. 2F) .
MASMCs subjected to long-term E 2 exposure (10 j8 M, 18 hours) were examined to determine whether E 2 alters the antioxidant effect of PGI 2 (15). E 2 stimulated COX-2 expression and PGI 2 formation as reflected by an increase in the PGI 2 hydrolysis product, 6-keto PGF 1a (from 2.4 T 0.33 to 3.8 T 0.38 ng/mg protein; *P G 0.05). Pretreatment of cells with E 2 (10 j8 M, 18 hours) attenuated the response to H 2 O 2 , as reflected by diminished release of the iP (Fig. 3B ), whereas direct coincubation of H 2 O 2 with E 2 had no effect (16) . E 2 administration (2 or 8 mg/day for 7 days) to ovariectomized LDLR KO mice increased PGI 2 biosynthesis, as reflected by increased excretion of the urinary PGI 2 metabolite 2,3-dinor 6-keto PGF 1a (PGI-M) (Fig. 3C ) (** P G 0.01 and *P G 0.05, respectively, versus their own respective baseline controls) and depressed urinary iP (Fig. 3D ) (*P G 0.05). Similarly, E 2 (Fig. 3E ) (**P G 0.05). Furthermore, E 2 (0.5 mg/day for 7 days) increased urinary PGI-M in female ERb KO mice but not in female ERa KO mice (Fig. 3F) . Thus, estrogen increases PGI 2 biosynthesis by activating ERa. LDLR KO and IP/LDLR DKO mice were bilaterally ovariectomized to assess the atheroprotective effect of exogenous E 2 in the absence of PGI 2 . One week after surgery, mice began feeding on a high-fat diet in the absence or presence of exogenous E 2 (8 mg/day) (15). After 3 months, aortic lesion area was significantly increased in the IP/LDLR DKO compared to the LDLR KO females (Fig. 4) . E 2 significantly reduced lesion burden (by È80%) in LDLR KO female mice (Fig. 4A) . However, coincidental deletion of the IP reduced this effect significantly (P G 0.0001) to 32%.
Rofecoxib, a selective inhibitor of COX-2, was withdrawn from clinical use when a placebo-controlled trial revealed an increase in myocardial infarction and stroke (20) . These patients were initially at low cardiovascular risk, and the hazard was detected after 18 months of treatment. Selective inhibitors of COX-2 depress PGI 2 , but not platelet COX-1-derived TxA 2 , which affords a mechanism whereby they might elevate blood pressure, accelerate atherogenesis, and augment the thrombotic response to plaque rupture (5, 21, 22) . Depression of PGI 2 may accelerate atherogenesis by multiple mechanisms, including augmenting platelet and neutrophil interactions with the vasculature (4, 5). PGI 2 also exerts an antioxidant effect, which may retard atherogenesis (14) . IP deletion augments lipid peroxidation, whereas its overexpression in human embryonic kidney cells has the opposite effect ( fig.  S1B ). An antioxidant role for PGI 2 , which may reflect induction of HO1, is consistent with exacerbation of reperfusion injury by IP deletion (23) .
Although extrapolation of results in mice to humans is performed with caution, the experience with rofecoxib has focused attention on the role of atherogenesis in transformation of cardiovascular risk during chronic treatment with selective inhibitors of COX-2 (20). We reveal a substantial contribution of ERa-mediated, COX-2-derived PGI 2 to atheroprotection in female LDLR KOs. This finding raises concern about the use of COX-2 inhibitors in juvenile arthritis, a disease that predominantly affects females. It may also have implications for the design and interpretation of trials of hormone-replacement therapy. 2 biosynthesis in ovariectomized LDLR KO mice (2 mg/day: **P G 0.05; 8 mg/day: *P G 0.05), coincident with (D) diminished urinary iP (2 mg/day: *P G 0.05; 8 mg/day: *P G 0.05). (E) An ERa-selective agonist (1.0 mM) elevates PGI 2 biosynthesis in MASMCs (**P G 0.01, fold over basal). (F) E 2 fails to increase PGI 2 biosynthesis in ovariectomized ERa KO mice. E 2 increases PGI 2 biosynthesis in ERb KO mice (*P G 0.05). Data are given as the mean T SEM, n 0 6 to 10 mice per group. Plants are constantly exposed to attack by an array of diverse pathogens but lack a somatically adaptive immune system. In spite of this, natural plant populations do not often suffer destructive disease epidemics. Elucidating how allelic diversity within plant genes that function to detect pathogens (resistance genes) counteracts changing structures of pathogen genes required for host invasion (pathogenicity effectors) is critical to our understanding of the dynamics of natural plant populations. The RPP13 resistance gene is the most polymorphic gene analyzed to date in the model plant Arabidopsis thaliana. Here we report the cloning of the avirulence gene, ATR13, that triggers RPP13-mediated resistance, and we show that it too exhibits extreme levels of amino acid polymorphism. Evidence of diversifying selection visible in both components suggests that the host and pathogen may be locked in a coevolutionary conflict at these loci, where attempts to evade host resistance by the pathogen are matched by the development of new detection capabilities by the host.
Disease resistance in plants is a complex process that provides many potential barriers to pathogen invasion. Among the plant_s defense arsenal are the disease resistance (R) genes, whose products trigger defense responses, such as localized host cell death, when challenged with pathogen isolates carrying matching avirulence genes (1). The largest class of R genes encodes proteins containing intra-or extracellular leucine-rich repeat (LRR) domains. LRR domains have been implicated in protein:protein interactions (2). However, direct interaction between an avirulence protein and its cognate R protein has been demonstrated in only a few host/ pathogen systems (3, 4) . Avirulence genes have been cloned from the fungal plant pathogens Cladosporium fulvum (5-7), Magnaporthe grisea (8), and Melampsora lini (9), but apart from the chitin-binding capacity of the Avr4 protein from C. fulvum (10), their roles in pathogenicity are unknown. We have recently shown the RPP13 (Recognition of Peronospora parasitica 13) resistance gene from Arabidopsis thaliana to be the most polymorphic gene so far analyzed in this species (11) . RPP13 encodes a CC:NB:LRR (coiled coil: nucleotide binding site:leucine rich repeat) protein, predicted to be cytoplasmically located, and the extreme variability of the protein was shown to reside within the LRR domain (11, 12) . This is consistent with the LRR domain experiencing diversifying selection. One selective agent could be a pathogen species exhibiting comparable levels of polymorphism in the avirulence protein detected via RPP13. From the plant_s perspective, there are two basic outcomes of a coevolutionary conflict: either a selective sweep in which a single allele of a resistance gene reaches high frequency in the plant population or balancing selection, in which a diverse cohort of resistance gene alleles is stably maintained (13) . The large number (19 among 24 Arabidopsis accessions) of diverse alleles present at the RPP13 locus implies that it is subject to balancing selection (11) . Haldane_s theory (14) suggests that coevolution of host and pathogen could lead to the maintenance of variation in both organisms. The interaction between Arabidopsis and the biotrophic oomycete Hyaloperonospora parasitica (formally Peronospora parasitica) is an excellent system in which to study such coevolution because both organisms coexist in extensive naturally occurring populations (15). Therefore, concomitant with extreme RPP13 gene diversity, we hypothesize that balancing selection on the pathogen gene products recognized by these R genes EATR13 (Arabidopsis thaliana recognised 13)^would also result in the maintenance of a highly polymorphic population of ATR13 alleles. Here we report the cloning of ATR13 and show that it is indeed under intense diversifying selection consistent with host/parasite conflict occurring between these two species. Both ATR13 and RPP13 are subject to balancing selection.
We previously isolated a range of H. parasitica genes EPpat (Peronospora parasitica in Arabidopsis thaliana)^that were up-regulated on infection of Arabidopsis (16) . Mapping of the Ppat sequences among 206 F 2 progeny of a cross between H. parasitica isolates Maks9 (predicted to contain ATR13) and Emoy2 (predicted to contain atr13) revealed cosegregation of a single-copy gene, Ppat17, and ATR13 (17). Therefore, Ppat17 was an ATR13 candidate.
Because no mechanism of genetic transformation has been established for H. parasitica, we developed a functional assay for ATR13 recognition based on a biolistic ap-
